The fertility test market size is estimated to be USD 498.65 million in 2021 and is expected to witness a CAGR of 7.91% during the forecast period 2022-2032. The rising number of women of reproductive age, the elevated emergence or launch of accurate, easy-to-use fertility testing devices, the increased awareness of fertility testing among women globally, and the rising incidence of gynaecological and reproductive problems in both men and women are some of the key drivers for the market growth. However, high cost of fertility testing monitors and the unproven accuracy of urine-based ovulation monitors in PCOD/PCOS patients are expected to restrain the market growth.

Segmentation

By Product

Based on product, the market is categorized into ovulation prediction kits, male fertility testing products, and fertility monitors. In 2021, the ovulation prediction kits accounted for the highest revenue share due to ovulation prediction kits’ low price, great efficiency, and easy availability.

By Mode of Purchase

Based on mode of purchase, the market is segmented into online products, direct/prescription-based products, and OTC-based products. In 2021, the OTC-based products segment accounted for the largest revenue share owing to increasing patient demand for remote and at-home monitoring, e-commerce accessibility, confidentiality of test results, and continued efforts by major market players to create reliable and user-friendly fertility test products.

By Application

On the basis of application, the market is categorized into male fertility products and female fertility products. In the global market, the female fertility segment accounted for the largest revenue share in 2021 owing to the rising female infertility rates, increased awareness among women about numerous fertility tests, the wide availability of different fertility test kits and options for females, and an upsurge in gynaecological issues like PCOD/PCOS in females.

By End User

Based on end user, the market is segmented into hospitals & fertility clinics, homecare settings, and others. In 2021, the homecare settings segment accounted for the largest revenue share owing to tendency of patients toward self-monitoring of healthcare conditions, the availability of user-friendly and simple-to-handle devices, the ease of access to fertility and ovulation monitors on e-commerce websites, and the increasing preference for the privacy of test results.

Regional Markets

In 2021, North America region accounted for the highest revenue in the fertility test market and is expected to maintain its dominance during the forecast period. This is attributed to rising prevalence of infertility, women’s growing awareness of fertility testing, the ageing of first-time mothers, and the wide distribution of fertility monitors on online shopping sites. Asia Pacific, on the other hand, is anticipated to experience the fastest increase during the forecast period. Population increase in countries like China and India, and surging demand for advanced fertility test equipment, are expected to promote market expansion in the APAC region.

Competitor Insights

Some of the key players operating in the fertility test market are bioZhena (US), Fertility Focus (UK), Hilin Life Products (US), Swiss Precision Diagnostics (Switzerland), UEBE Medical (Germany), AdvaCare Pharma (US), Babystart (UK), Geratherm Medical (Germany), Church & Dwight (US), Fairhaven Health (US), Valley Electronics (Germany), Prestige Brands Holdings (US), Sensiia (UK), AVA (Switzerland), and Mira Care (US).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, mode of purchase, application, and end user from 2021 to 2032.

Report Scope:

Segmentation: Fertility Test Market Report 2021- 2032

Product (Revenue, USD Million)

• Ovulation Prediction Kits
• Male Fertility Testing Products
• Fertility Monitors

Mode of Purchase (Revenue, USD Million)

• Online Products
• Direct/Prescription-based Products
• OTC-based Products

Application (Revenue, USD Million)

• Male Fertility Products
• Female Fertility Products

End user (Revenue, USD Million)

• Hospitals & Fertility Clinics
• Homecare Settings
• Others

By Region (Revenue, USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA